State Of Wyoming Esperion Therapeutics, Inc. Transaction History
State Of Wyoming
- $754 Million
- Q4 2024
A detailed history of State Of Wyoming transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, State Of Wyoming holds 46,410 shares of ESPR stock, worth $85,858. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,410
Previous 77,800
40.35%
Holding current value
$85,858
Previous $128,000
20.31%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding ESPR
# of Institutions
215Shares Held
129MCall Options Held
1.78MPut Options Held
1.27M-
Wasatch Advisors Inc Salt Lake City, UT24.5MShares$45.3 Million0.27% of portfolio
-
Black Rock Inc. New York, NY14MShares$25.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$21.7 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.94MShares$18.4 Million0.44% of portfolio
-
Morgan Stanley New York, NY6.31MShares$11.7 Million0.0% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $123M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...